Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug
Christopher W. Schultz, Avinoam Nevler
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3249-3249
Open Access | Times Cited: 20

Showing 20 citing articles:

Tetracycline antibiotics: Potential anticancer drugs
Jiayu Li, Yuan Qin, Chenhao Zhao, et al.
European Journal of Pharmacology (2023) Vol. 956, pp. 175949-175949
Closed Access | Times Cited: 16
Targeting Stem Cells and Dysplastic Features With Dual MEK/ERK and STAT3 Suppression in Gastric Carcinogenesis
Hyesung Kim, Bo Gun Jang, Changqing Zhang, et al.
Gastroenterology (2023) Vol. 166, Iss. 1, pp. 117-131
Open Access | Times Cited: 12
Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma
Luyu Liu, Pan Yin, Ruida Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
In Vitro and Ex Vivo Synergistic Effect of Pyrvinium Pamoate Combined with Miltefosine and Paromomycin against Leishmania
Estela Melcón-Fernández, Giulio Galli, Rafael Balaña‐Fouce, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 2, pp. 30-30
Open Access | Times Cited: 3
Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 949-949
Open Access | Times Cited: 3
Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses
Andrés López‐Cortés, Alejandro Cabrera‐Andrade, Gabriela Echeverría‐Garcés, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Toxic Effects of Penetrating Cations
С. С. Соколов, Anna Zyrina, Sergey A. Akimov, et al.
Membranes (2023) Vol. 13, Iss. 10, pp. 841-841
Open Access | Times Cited: 7
Nuclear speckle rejuvenation alleviates proteinopathies at the expense of YAP1
William Dion, Yuren Tao, Maci Chambers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
pyHeart4Fish: Chamber-specific heart phenotype quantification of zebrafish in high-content screens
Viviana L. Vedder, Tobias Reinberger, Syed Muhammad Ijlal Haider, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Wnt Signaling in Atherosclerosis: Mechanisms to Therapeutic Implications
Rizwana Afroz, Julie E. Goodwin
Biomedicines (2024) Vol. 12, Iss. 2, pp. 276-276
Open Access | Times Cited: 1
Metabolic vulnerability of cancer stem cells and their niche
Laura Marrone, Simona Romano, Chiara Malasomma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
A High‐Throughput Drug Repurposing Strategy to Treat TBX2 and/or TBX3 Dependent Cancers
Jenna Bleloch, Sizhu Lu, Saif F. Khan, et al.
Cancer Medicine (2024) Vol. 13, Iss. 19
Open Access | Times Cited: 1
Unlocking Benzosampangine’s Potential: A Computational Approach to Investigating, Its Role as a PD-L1 Inhibitor in Tumor Immune Evasion via Molecular Docking, Dynamic Simulation, and ADMET Profiling
Abderrahim Ait Ouchaoui, Salah Eddine El Hadad, Marouane Aherkou, et al.
Bioinformatics and Biology Insights (2024) Vol. 18
Open Access | Times Cited: 1
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models
Karabo Serala, Jinming Bai, Sharon Prince
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 23
Closed Access | Times Cited: 1
Toxic Effects of Penetrating Cations
С. С. Соколов, Anna Zyrina, Sergey A. Akimov, et al.
(2023)
Open Access | Times Cited: 2
Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma
Jiawen Yang, James T. Lim, Paul Victor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?
Mainak Bardhan, Debankur Dey, Vinay Suresh, et al.
Expert Review of Neurotherapeutics (2023) Vol. 24, Iss. 1, pp. 77-103
Closed Access | Times Cited: 2
Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma
Luyu Liu, Pan Yin, Yang Ruida, et al.
Research Square (Research Square) (2024)
Open Access
Pyrvinium Pamoate Enhances the Anti-cancer Activities of Gemcitabine in Pancreatic Cancer
Karabo Serala, Jinming Bai, Sharon Prince
(2024)
Open Access
Page 1

Scroll to top